Within six families, a path to personalized treatment for an immune disorder
Wednesday, March 16, 2016 - 20:20
in Health & Medicine
The most common immune disorder, common variable immunodeficiency disorder (CVID), is notoriously difficult to diagnose early, before serious complications develop. Genetic analysis of six families from across the U.S. and Europe has revealed that mutations in IKAROS, known for its central role in immune cell development, define a new class of CVID. This study's results open the door to personalized health care tailored to patients with this disorder.